Alice Demesmaeker, Fabien D'Hondt, Ali Amad, Guillaume Vaiva, Arnaud Leroy
{"title":"法国ALGOS研究中的创伤后应激障碍和再自杀风险。","authors":"Alice Demesmaeker, Fabien D'Hondt, Ali Amad, Guillaume Vaiva, Arnaud Leroy","doi":"10.4088/JCP.24m15269","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> The specific role of posttraumatic stress disorder (PTSD) in individuals who have attempted suicide, along with the influence of comorbid psychiatric conditions on the risk of suicide reattempt, remains unexplored. This study aims to assess the association between PTSD and suicide reattempt at 6 months among suicide attempt (SA) survivors, while controlling for prevalent psychiatric disorders.</p><p><p><b>Method:</b> We analyzed data from a cohort of 972 participants enrolled in the ALGOS study between January 2010 and February 2013. We assessed the risk of suicide reattempt at 6 months and rehospitalization in both psychiatric and nonpsychiatric settings. A multivariable logistic regression model was performed, controlling for depression, generalized anxiety disorder, and alcohol use disorder.</p><p><p><b>Results:</b> Among all participants, 79 had a lifetime diagnosis of PTSD. At 6 months, 117 participants (13.3%) had reattempted suicide. After controlling for randomization group, age, sex, and comorbid psychiatric conditions, PTSD was statistically associated with suicide reattempt at 6 months (odds ratio [OR] with 95% CI, 2.33 [1.39-3.89], <i>P</i> < .01), rehospitalization in psychiatric settings (OR = 2.24 [1.39-3.61], <i>P</i> < .01), and nonpsychiatric settings (OR = 3.06 [1.90-4.93], <i>P</i> < .01).</p><p><p><b>Conclusion:</b> Almost 1 in 10 SA survivors suffer from PTSD. These individuals are at a higher risk of suicide reattempt and appear more generally to be in poorer health, with a higher risk of hospitalization in psychiatric and nonpsychiatric settings. Recognizing and effectively managing PTSD among individuals admitted after an SA is thus imperative for reducing the risk of subsequent suicide reattempts.</p>","PeriodicalId":50234,"journal":{"name":"Journal of Clinical Psychiatry","volume":"85 4","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Posttraumatic Stress Disorder and Risk of Suicide Reattempt in the French ALGOS Study.\",\"authors\":\"Alice Demesmaeker, Fabien D'Hondt, Ali Amad, Guillaume Vaiva, Arnaud Leroy\",\"doi\":\"10.4088/JCP.24m15269\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> The specific role of posttraumatic stress disorder (PTSD) in individuals who have attempted suicide, along with the influence of comorbid psychiatric conditions on the risk of suicide reattempt, remains unexplored. This study aims to assess the association between PTSD and suicide reattempt at 6 months among suicide attempt (SA) survivors, while controlling for prevalent psychiatric disorders.</p><p><p><b>Method:</b> We analyzed data from a cohort of 972 participants enrolled in the ALGOS study between January 2010 and February 2013. We assessed the risk of suicide reattempt at 6 months and rehospitalization in both psychiatric and nonpsychiatric settings. A multivariable logistic regression model was performed, controlling for depression, generalized anxiety disorder, and alcohol use disorder.</p><p><p><b>Results:</b> Among all participants, 79 had a lifetime diagnosis of PTSD. At 6 months, 117 participants (13.3%) had reattempted suicide. After controlling for randomization group, age, sex, and comorbid psychiatric conditions, PTSD was statistically associated with suicide reattempt at 6 months (odds ratio [OR] with 95% CI, 2.33 [1.39-3.89], <i>P</i> < .01), rehospitalization in psychiatric settings (OR = 2.24 [1.39-3.61], <i>P</i> < .01), and nonpsychiatric settings (OR = 3.06 [1.90-4.93], <i>P</i> < .01).</p><p><p><b>Conclusion:</b> Almost 1 in 10 SA survivors suffer from PTSD. These individuals are at a higher risk of suicide reattempt and appear more generally to be in poorer health, with a higher risk of hospitalization in psychiatric and nonpsychiatric settings. Recognizing and effectively managing PTSD among individuals admitted after an SA is thus imperative for reducing the risk of subsequent suicide reattempts.</p>\",\"PeriodicalId\":50234,\"journal\":{\"name\":\"Journal of Clinical Psychiatry\",\"volume\":\"85 4\",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4088/JCP.24m15269\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4088/JCP.24m15269","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
目的:创伤后应激障碍(PTSD)在企图自杀的个体中的具体作用,以及共病精神疾病对自杀再企图风险的影响,尚不清楚。本研究旨在评估自杀未遂(SA)幸存者6个月后PTSD与自杀再企图之间的关系,同时控制流行的精神疾病。方法:我们分析了2010年1月至2013年2月期间加入ALGOS研究的972名参与者的数据。我们评估了在精神科和非精神科环境中6个月时再次自杀企图和再次住院的风险。采用多变量logistic回归模型,控制抑郁、广泛性焦虑障碍和酒精使用障碍。结果:在所有参与者中,79人终生诊断为PTSD。6个月后,117名参与者(13.3%)再次试图自杀。在控制随机分组、年龄、性别和共病精神状况后,PTSD与6个月时自杀再企图(比值比[OR], 95% CI, 2.33 [1.39-3.89], P < 0.01)、精神科再住院(OR = 2.24 [1.39-3.61], P < 0.01)和非精神科再住院(OR = 3.06 [1.90-4.93], P < 0.01)有统计学意义。结论:近十分之一的SA幸存者患有PTSD。这些人再次自杀的风险更高,健康状况更差,在精神病院和非精神病院住院的风险更高。因此,在SA后入院的个体中识别和有效地管理PTSD对于降低随后的自杀再企图的风险是必要的。
Posttraumatic Stress Disorder and Risk of Suicide Reattempt in the French ALGOS Study.
Objective: The specific role of posttraumatic stress disorder (PTSD) in individuals who have attempted suicide, along with the influence of comorbid psychiatric conditions on the risk of suicide reattempt, remains unexplored. This study aims to assess the association between PTSD and suicide reattempt at 6 months among suicide attempt (SA) survivors, while controlling for prevalent psychiatric disorders.
Method: We analyzed data from a cohort of 972 participants enrolled in the ALGOS study between January 2010 and February 2013. We assessed the risk of suicide reattempt at 6 months and rehospitalization in both psychiatric and nonpsychiatric settings. A multivariable logistic regression model was performed, controlling for depression, generalized anxiety disorder, and alcohol use disorder.
Results: Among all participants, 79 had a lifetime diagnosis of PTSD. At 6 months, 117 participants (13.3%) had reattempted suicide. After controlling for randomization group, age, sex, and comorbid psychiatric conditions, PTSD was statistically associated with suicide reattempt at 6 months (odds ratio [OR] with 95% CI, 2.33 [1.39-3.89], P < .01), rehospitalization in psychiatric settings (OR = 2.24 [1.39-3.61], P < .01), and nonpsychiatric settings (OR = 3.06 [1.90-4.93], P < .01).
Conclusion: Almost 1 in 10 SA survivors suffer from PTSD. These individuals are at a higher risk of suicide reattempt and appear more generally to be in poorer health, with a higher risk of hospitalization in psychiatric and nonpsychiatric settings. Recognizing and effectively managing PTSD among individuals admitted after an SA is thus imperative for reducing the risk of subsequent suicide reattempts.
期刊介绍:
For over 75 years, The Journal of Clinical Psychiatry has been a leading source of peer-reviewed articles offering the latest information on mental health topics to psychiatrists and other medical professionals.The Journal of Clinical Psychiatry is the leading psychiatric resource for clinical information and covers disorders including depression, bipolar disorder, schizophrenia, anxiety, addiction, posttraumatic stress disorder, and attention-deficit/hyperactivity disorder while exploring the newest advances in diagnosis and treatment.